Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03440762 · ClinicalTrials.gov registry record · NA
Atrial Fibrillation Screening and Education Study
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT03440762: Completed NA study, sponsored by Mayo Clinic.
NCT03440762 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 83 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03440762, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the outcomes of a community placed atrial fibrillation (AF) screening and education program
Primary Outcome
number of participants enrolled
Interventions
- BEHAVIORAL AF awareness education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2017-08-16 |
| Est. Completion | 2019-08-27 |
| Phase | NA |
What the finished NCT03440762 record still lists
NCT03440762 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which AF awareness education is the first listed.
NCT03440762 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03440762 about?
NCT03440762 is a clinical study titled "Atrial Fibrillation Screening and Education Study". The purpose of this study is to evaluate the outcomes of a community placed atrial fibrillation (AF) screening and education program
What is the current status of trial NCT03440762?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2017-08-16. Estimated completion is 2019-08-27.
What interventions are being tested in trial NCT03440762?
The interventions under investigation include: AF awareness education (BEHAVIORAL).
Who is sponsoring clinical trial NCT03440762?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03440762's enrollment target sits among peer trials
83 990th of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI